AeroLeads people directory · profile
Michael Comeau Email & Phone Number
Associate Director, Strategic Scientific Alliances
at
Ozette Technologies
1 work email found
@silverbacktx.com
1 phone found area 206
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Associate Director, Strategic Scientific Alliances
Location
Seattle, Washington, United States
Company size
Who is Michael Comeau? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Comeau is listed as Associate Director, Strategic Scientific Alliances at Ozette Technologies, a with 29 employees, based in Seattle, Washington, United States. AeroLeads shows a work email signal at silverbacktx.com, phone signal with area code 206, and a matched LinkedIn profile for Michael Comeau.
Michael Comeau previously worked as Associate Director, Strategic Scientific Alliances at Ozette and Senior Scientific Affairs Liaison at Ozette. Michael Comeau holds B.S., Microbiology/Molecular Biology from Washington State University.
Company email context
Email format at Ozette Technologies
This section adds company-level context without repeating Michael Comeau's masked contact details.
{first_initial}{last}@silverbacktx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Comeau. Compare company email patterns before reaching out.
Profile bio
About Michael Comeau
Accomplished biopharmaceutical research scientist with experience on clinical stage immuno-oncology and inflammation focused therapeutic programs and a demonstrated track record of cutting-edge research discoveries and high impact contributions. SELECTED ACCOMPLISHMENTSTeam Leader and Key Contributor• Project team leader for APVO436, a bispecific anti-CD123 x anti-CD3 antibody currently being tested in phase I trials for hematological malignancies• Initiated and led the project team in the successful development of Tezepelumab. An effort leading to robust human clinical data published in the New England Journal of Medicine in 2014. Program is currently being tested in global phase 3 trials.• Leader of pre-clinical asthma discovery research efforts charged with developing and communicating strategy for therapeutic target discovery and disease stratification• Extensive experience collaborating with external academic researchers and CROs.Innovation• Excellent record of high impact publications (primary peer-reviewed articles, book chapters, invited reviews) and contributions to Amgen IP• Described novel TSLP biology involving dendritic cells, mast cells, eosinophils, basophils, type 2 innate lymphoid cells and link between TSLP over-expression and atopic dermatitis, asthma and eosinophilic esophagitis• Experienced bench scientist with the ability to contribute to project needs in the laboratory • Involved in cloning and biologic characterization of numerous novel genes and cytokine receptor chainsCommunicator• Extensive experience with project portal presentations, therapeutic area strategy reviews, CEO level overviews, review and presentation of licensing and partnering opportunities• Consistent presentation of abstracts and talks at major external scientific conferences• Developed and delivered AMG 157 project overview presentations to several biopharmaceutical companies around the globeAuthor on 52 Publications and Holder of 8 Patents
Listed skills include Monoclonal Antibodies, In Vitro, Immunology, Cell Biology, and 22 others.
Current workplace
Michael Comeau's current company
Company context helps verify the profile and gives searchers a useful next step.
Ozette Technologies
10 roles
Michael Comeau work experience
A career timeline built from the work history available for this profile.
Associate Director, Strategic Scientific Alliances
Current
Jul 2024 - Present
Senior Scientific Affairs Liaison
Jan 2023 - Jul 2024
Director Of Biology
Nov 2021 - Jan 2023
Principal Scientist
Jun 2019 - Nov 2021
Oct 2015 - Jun 2019
Principal Scientist
Initiated and led the project team in the successful development of AMG 157, a fully human antibody capable of inhibiting TSLP activity. A multi-year effort requiring cross-site and departmental team work leading to robust human clinical data published in the New England Journal of Medicine in 2014. Program is currently being tested in a global phase 2 human asthma trial.Developed and delivered AMG 157 project overview presentations to several biopharmaceutical companies around the globe leading to successful establishment of Amgen partnership with AstraZeneca/MedImmune to co-develop the program.Co-leader of pre-clinical asthma discovery research efforts at Amgen charged with developing and communicating strategy for therapeutic target discovery and disease stratification. Led cross-site team of 20 scientist and technical staff responsible for executing on strategy, initiating early stage pipeline projects, establishing new platforms for interrogation of therapeutic targets and developing stratification and biomarker approaches.Managed and mentored Senior Scientist through technical level staff.Led inflammation research efforts to acquire patient samples for asthma research establishing numerous human tissue acquisition collaborations and phase 0 studies.Initiated and led project teams focused on development of both monoclonal and multi-specific antibody based therapies for inflammatory disease.Contributed to licensing evaluations, legal filings and IND submissions.Developed extensive global academic research network.Delivered project portal presentations, therapeutic area strategy reviews, CEO level overviews, review and presentation of licensing and partnering opportunities.Managed in-house Amgen blood donor program at Seattle site. Program encompassed over 100 donors and provided internal researchers with whole blood and purified immune cell populations.
Jan 2008 - Oct 2014
Senior Scientist
Jan 2004 - Jan 2008
Scientist
Jan 2001 - Jan 2004
Research Assistant - Associate Staff Scientist
Amgen purchased Immunex and I remained at Amgen
Oct 1989 - Jul 2001
2 education records
Michael Comeau education
B.S., Microbiology/Molecular Biology
Washington State University
Biology Major
University Of Alaska
FAQ
Frequently asked questions about Michael Comeau
Quick answers generated from the profile data available on this page.
What company does Michael Comeau work for?
Michael Comeau works for Ozette Technologies.
What is Michael Comeau's role at Ozette Technologies?
Michael Comeau is listed as Associate Director, Strategic Scientific Alliances at Ozette Technologies.
What is Michael Comeau's email address?
AeroLeads has found 1 work email signal at @silverbacktx.com for Michael Comeau at Ozette Technologies.
What is Michael Comeau's phone number?
AeroLeads has found 1 phone signal(s) with area code 206 for Michael Comeau at Ozette Technologies.
Where is Michael Comeau based?
Michael Comeau is based in Seattle, Washington, United States while working with Ozette Technologies.
What companies has Michael Comeau worked for?
Michael Comeau has worked for Ozette Technologies, Ozette, Silverback Therapeutics, Aptevo Therapeutics Inc, and Amgen, Inc.
How can I contact Michael Comeau?
You can use AeroLeads to view verified contact signals for Michael Comeau at Ozette Technologies, including work email, phone, and LinkedIn data when available.
What schools did Michael Comeau attend?
Michael Comeau holds B.S., Microbiology/Molecular Biology from Washington State University.
What skills is Michael Comeau known for?
Michael Comeau is listed with skills including Monoclonal Antibodies, In Vitro, Immunology, Cell Biology, Pharmacology, Molecular Biology, Biotechnology, and Antibodies.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial